Pleguezuelos Eulogio, Esquinas Cristina, Moreno Eva, Guirao Lluis, Ortiz Javier, Garcia-Alsina Joan, Merí Alex, Miravitlles Marc
Physical Medicine and Rehabilitation Department, Hospital Mataró, C/Cirera s/n 08302, Mataró, Barcelona, Spain.
Department of Experimental Science and Healthcare, Faculty of Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Lung. 2016 Apr;194(2):249-57. doi: 10.1007/s00408-015-9838-z. Epub 2016 Jan 7.
Muscular dysfunction has been described as one of the systemic manifestations of chronic obstructive pulmonary disease (COPD).
The aim of this study was to evaluate muscular strength of the different anatomical compartments in patients with severe COPD compared with healthy controls.
We performed a cross-sectional study in patients with severe COPD. We evaluated the muscular strength of the respiratory muscles, flexors and extensors of the cervical spine and knee, as well as handgrip force. The 6-min walking test (6MWT) and serum inflammatory markers were also analysed.
Twenty-eight male patients with COPD (mean age 67.8 years, mean FEV1 (%) 39 %) and 24 male healthy controls (mean age 70.2 years) were studied. The strength of the flexors and extensors of the knee was significantly reduced in patients with COPD (p < 0.001 and p = 0.003). No differences were observed in the flexors and extensors of the cervical spine and handgrip force between groups. No correlation was observed between the muscular strength in the different anatomic compartments and the concentrations of blood inflammatory biomarkers or the metres walked in the 6MWT in COPD patients. However, a significant negative linear correlation was observed between the 6MWT and IL-6 and IL-8 levels (rho = -0.67, p = 0.001; rho = -0.57, p = 0.008). In addition, we found a negative correlation between the 6MWT and inspiratory capacity (rho = -0.755, p = 0.031).
Our results suggest that muscular dysfunction in patients with COPD differs in different muscular compartments. The main factor for a reduced exercise capacity was a reduction in inspiratory capacity.
肌肉功能障碍已被描述为慢性阻塞性肺疾病(COPD)的全身表现之一。
本研究旨在评估重度COPD患者与健康对照者不同解剖部位的肌肉力量。
我们对重度COPD患者进行了一项横断面研究。我们评估了呼吸肌、颈椎和膝关节屈伸肌的肌肉力量以及握力。还分析了6分钟步行试验(6MWT)和血清炎症标志物。
研究了28例男性COPD患者(平均年龄67.8岁,平均第一秒用力呼气容积(FEV1)(%)为39%)和24例男性健康对照者(平均年龄70.2岁)。COPD患者膝关节屈伸肌力量显著降低(p<0.001和p = 0.003)。两组之间颈椎屈伸肌和握力未观察到差异。COPD患者不同解剖部位的肌肉力量与血液炎症生物标志物浓度或6MWT中行走的米数之间未观察到相关性。然而,6MWT与白细胞介素-6(IL-6)和白细胞介素-8(IL-8)水平之间观察到显著的负线性相关性(rho = -0.67,p = 0.001;rho = -0.57,p = 0.008)。此外,我们发现6MWT与吸气容量之间存在负相关(rho = -0.755,p = 0.031)。
我们的结果表明,COPD患者的肌肉功能障碍在不同肌肉部位有所不同。运动能力降低的主要因素是吸气容量减少。